The King Saud City Research and Innovation Center and VALO HEALTH announce their multi-year collaboration to provide preventive care and personalized medicine to patients.


Cooperation to benefit from the biobank of King Fahd Medical City – the largest in Israel and the most comprehensive in the world

BostonAnd the September 19, 2022 /PRNewswire/ – Kahn-Sagol-Maccabi (KSM), Center for Research and Innovation in the Israel Leading HMO – Maccabi Healthcare Services and Valo Health, Inc. (“Valo”), the technology company focused on transforming drug discovery and development using human-centric data and artificial intelligence, today announced the launch of a first-of-its-kind multi-year collaboration in which Biobank of Valo and Maccabi KSM Research and Innovation will jointly conduct research that leverages Valo’s Opal Computational Platform™ for defining preventive care and personalized medicine for patients.

The collaboration between Valo and KSM’s Biobank, which is the largest in Israel and one of the most comprehensive and richest data sets globally, is expected to lead to innovative studies analyzing complex diseases, identifying links between diseases, predicting new subpopulations within our existing knowledge of diseases and creating new insights About the treatment and prevention of diseases using the Valo Opal platform. KSM’s Biobank houses more than 800,000 unidentified biological samples from volunteers from McCabe members who have agreed to join the Biobank project to advance genetic research.

Valo Founder and CEO said: “Valo is honored to launch this unique collaboration with Maccabi KSM.” David Berry. “As a leader in fully integrating and leveraging patient data with AI-powered computational capabilities, Valo is well positioned to generate significant value for Maccabi patients by identifying insights to help identify and treat complex diseases early and support better treatment decisions.”

Dr. said. Batalon Hill, head of KSM. “The goal is to make a leap forward in the areas of medical innovation and personalized medicine.”

About Kahn-Sagol-Maccabi (KSM):

Kahn-Sagol-Maccabi (KSM) is the research and innovation center for healthcare services in Maccabi, Israel Leading HMO. KSM has unique access to Maccabi’s professional capabilities and medical knowledge, including a large database of 2.5 million members with 30 years of data collection. For more details, visit www.ksminnovation.com.

About Valo Health:

Valo Health, Inc. (“Valo”) is a technology company created to transform drug discovery and development using human-centric data and artificial intelligence-based computation. As a digital on-premises company, Valo aims to fully integrate human-centric data across the entire drug development lifecycle into a single unified architecture, thus accelerating the discovery and development of life-changing drugs while simultaneously reducing costs, time, and failure rates. The company’s Opal computing platform is an integrated set of capabilities designed to transform data into valuable insights that may accelerate discoveries and enable Valo to develop a robust pipeline of software across renal cardiovascular metabolism, oncology and neurodegenerative diseases. Founded by Flagship Pioneering and headquartered in Boston, MassachusettsValo also has offices in San Francisco, CaliforniaAnd the New York, New YorkAnd the Lexington, MassachusettsAnd the Branford, Connecticut. To find out more, visit www.valohealth.com.

Contacts:

The media: Jennifer HanleyVP Corporate Communications [email protected] valohealth.com

Investors: Graeme BellChief Financial Officer [email protected] Valhealth. com

Source: Valo Health, Inc.


Leave a Reply

Your email address will not be published.